In today’s hospitals and healthcare clinics, a new doctor’s new assistant is now often on the job — in the form of artificial intelligence. Whether it’s analyzing medical images or guiding robots that assist with surgeries, AI is making steady inroads into our hospitals and clinics. Need an online nursing assistant or a watchdog that helps detect dosage errors? There’s an AI application for that.
The advent of AI in healthcare is a promising trend in terms of both patient care and economic efficiency. AI can help us address a forecasted shortage of physicians, particularly in specialty-care fields, while containing the costs of caring for an aging and growing population. A recent study by a team of researchers from the consulting firm Accenture found that the use of 10 promising AI applications could create up to $150 billion in annual savings for U.S. healthcare by 2026.
For an example of the potential of AI in healthcare, we need to look no further than Gustave Roussy, a leading European center for cancer research and care. In a study published this summer in the medical journal The Lancet Oncology, a team of medical researchers from Gustave Roussy and a few other institutions demonstrated that AI can process medical images to extract biological and clinical information to help with immunotherapy treatment, according to a news release on the study.
In this groundbreaking study, the researchers used an algorithm they designed and developed to analyze CT scan images and create a “radiomic signature.” This signature defines the level of lymphocyte infiltration of a tumor — or the degree to which immune cells have moved from the blood into a tumor cell. The radiomic signature also provides a predictive score for the efficacy of immunotherapy in the patient.
Here’s how AI played into this research: Using an approach based on machine learning, the team first taught the algorithm to use relevant information extracted from CT scans of patients participating in the study. Then, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumor immune infiltrate, and it established the radiomic signature.
The announcement summarizing the findings of the study notes that in the future, physicians might be able to use imaging to identify biological phenomena in a tumor located in any part of the body without having to perform a biopsy.
At Dell EMC, this research is particularly close to our hearts because we are active supporters of Gustave Roussy.
Image Credit: Dell EMC
News This Week
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]